{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:55:24Z","timestamp":1776329724041,"version":"3.50.1"},"reference-count":19,"publisher":"Baskent University","issue":"Suppl 5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.6002\/ect.pedsymp2024.o25","type":"journal-issue","created":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T06:45:11Z","timestamp":1730357111000},"source":"Crossref","is-referenced-by-count":0,"title":[],"prefix":"10.6002","volume":"22","member":"4021","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Feldman AG, Sokol RJ. Neonatal cholestasis. Neoreviews 2013;14:e63-e73. doi:10.1542\/neo.14-2-e63","DOI":"10.1542\/neo.14-2-e63"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Gotze T, Blessing H, Grillhosl C, Gerner P, Hoerning, A. Neonatal cholestasis: differential diagnoses, current diagnostic procedures, and treatment. Front Pediatr. 2015;3:43. doi:10.3389\/fped.2015.00043","DOI":"10.3389\/fped.2015.00043"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Bull LN, Ellmers R, Foskett P, et al. Cholestasis due to USP53 deficiency. J Pediatr Gastroenterol Nutr. 2021;72(5):667-673. doi:10.1097\/MPG.0000000000002926","DOI":"10.1097\/MPG.0000000000002926"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. McKiernan PJ. Neonatal cholestasis. Semin Neonatol. 2002;7:153-165. doi:10.1053\/siny.2002.0103","DOI":"10.1053\/siny.2002.0103"},{"key":"ref4","unstructured":"5. Fayyad A, Shagrani M, AlGoufi T, et al. Progress and outcomes of the first high-volume pediatric liver transplantation program in Saudi Arabia. Clin Transpl. 2013:77-83."},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Maddirevula S, Alhebbi H, Alqahtani A, et al. Identification of novel loci for pediatric cholestatic liver disease defined by KIF12, PPM1F, USP53, LSR, and WDR83OS pathogenic variants. Genet Med. 2019;21(5):1164-1172. doi:10.1038\/s41436-018-0288-x","DOI":"10.1038\/s41436-018-0288-x"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Sticova E, Jirsa M, Paw\u0142owska J. New insights in genetic cholestasis: from molecular mechanisms to clinical implications. Can J Gastroenterol Hepatol. 2018;2018:2313675. doi:10.1155\/2018\/2313675","DOI":"10.1155\/2018\/2313675"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Quesada V, Di\u0301az-Perales A, Gutie\u0301rrez-Ferna\u0301ndez A, Garabaya C, Cal S, Lo\u0301pez-Oti\u0301n C. Cloning and enzymatic analysis of 22 novel human ubiquitin-specific proteases. Biochem Biophys Res Commun. 2004;314(1):54-62. doi:10.1016\/j.bbrc.2003.12.050","DOI":"10.1016\/j.bbrc.2003.12.050"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Zhang J, Yang Y, Gong JY, et al. Low-GGT intrahepatic cholestasis associated with biallelic USP53 variants: clinical, histological and ultrastructural characterization. Liver Int. 2020;40(5):1142-1150. doi:10.1111\/liv.14422","DOI":"10.1111\/liv.14422"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Kazmierczak M, Harris SL, Kazmierczak P, et al. Progressive hearing loss in mice carrying a mutation in Usp53. J Neurosci. 2015;35(47):15582-15598. doi:10.1523\/JNeurosci.1965-15.2015","DOI":"10.1523\/JNEUROSCI.1965-15.2015"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Heinemamm U, Schuetz A. Structural features of tight-junction proteins. Int J Mol Sci. 2019;20:6020. doi:10.3390\/ijms20236020","DOI":"10.3390\/ijms20236020"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Roehlen N, Roca Suarez AA, El Saghire H, et al. Tight junction proteins and the biology of hepatobiliary disease. Int J Mol Sci. 2020;21(3):825. doi:10.3390\/ijms21030825","DOI":"10.3390\/ijms21030825"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Carlton VE, Harris BZ, Puffenberger EG, et al. Complex inheritance of familial hypercholanemia with associated mutations in Tjp2 and BAAT. Nat Genet. 2003;34:91-96. doi:10.1038\/ng1147","DOI":"10.1038\/ng1147"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Sambrotta M, Strautnieks S, Papouli E, et al. Mutations in TJP2 cause progressive cholestatic liver disease. Nat Genet. 2014;46:326-328. doi:10.1038\/ng.2918","DOI":"10.1038\/ng.2918"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Alhebbi H, Peer-Zada AA, Al-Hussaini AA, et al. New paradigms of USP53 disease: normal GGT cholestasis, BRIC, cholangiopathy, and responsiveness to rifampicin. J Hum Genet. 2021;66(2):151-159. doi:10.1038\/s10038-020-0811-1","DOI":"10.1038\/s10038-020-0811-1"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Pawlikowska L, Groen A, Eppens EF, et al. A mouse genetic model for familial cholestasis caused by ATP8B1 mutations reveals perturbed bile salt homeostasis but no impairment in bile secretion. Hum Mol Genet. 2004;13(8):881-892. doi:10.1093\/hmg\/ddh100","DOI":"10.1093\/hmg\/ddh100"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Vij M, Sankaranarayanan S. Biallelic mutations in ubiquitin-specific peptidase 53 (USP53) causing progressive intrahepatic cholestasis. Report of a case with review of literature. Pediatr Dev Pathol. 2022;25(2):207-212. doi:10.1177\/10935266211051175","DOI":"10.1177\/10935266211051175"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Ye Y, Scheel H, Hofmann K, Komander D. Dissection of USP catalytic domains reveals five common insertion points. Mol Biosyst. 2009;5(12):1797-808. doi:10.1039\/b907669g","DOI":"10.1039\/b907669g"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405-424. doi:10.1038\/gim.2015.30","DOI":"10.1038\/gim.2015.30"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T07:39:11Z","timestamp":1730360351000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ectrx.org\/detail\/supplement\/2024\/22\/10\/5\/149\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":19,"journal-issue":{"issue":"Suppl 5","published-print":{"date-parts":[[2024,10]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.pedsymp2024.o25","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10]]}}}